Clinical Trials
15 trialsNCT07585331 2026-05-13
Towards Effective, Patient-tailored Anti-plasma Cell Therapies in AL Amyloidosis: Predicting Drug Response and Overcoming Drug Resistance
Fondazione IRCCS Policlinico San Matteo di Pavia
Completed
NCT03431896 2026-03-12
MED-hATTR
The Cleveland Clinic
Completed
NCT04615572 2024-10-28
Screening to Improve Survival in AL Amyloidosis
Tufts Medical Center
Completed
NCT04659798 2024-07-08
DOrianT
Takeda
Completed
NCT04937777 2022-09-27
A Study on the Management and Outcome of Patients With Systemic AL Amyloidosis in Europe
European Myeloma Network B.V.
Completed
NCT03886155 2021-12-22
CAST
The Cleveland Clinic
Completed
NCT03923920 2021-12-22
ALF
The Cleveland Clinic
Completed
NCT02716103 2021-09-10
MRD
Boston Medical Center
Completed
NCT02555969 2020-08-24
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis
Tufts Medical Center
Completed
NCT02574676 2019-04-09
Quality of Life (QOL) Registry for Patients With AL Amyloidosis
Prothena Biosciences Ltd.
Completed
NCT00445952 2018-02-01
Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
European Organisation for Research and Treatment of Cancer - EORTC
Completed
NCT00993694 2017-04-17
Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone
Vanderbilt University Medical Center
Completed
NCT02257905 2015-07-24
Allo SCT in Amyloidosis Non-interventional Study
European Society for Blood and Marrow Transplantation
Completed
NCT00919139 2015-04-03
S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
SWOG Cancer Research Network
Completed
NCT00898066 2015-03-06
S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG Cancer Research Network
Completed